Dishman Pharmaceuticals & Chemicals | DISHMAN | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2015 | 2016 | 2017 | 2018 | |
---|---|---|---|---|---|
Cash and cash equiva... |
| 362 | 622 | 874 | 691 |
Short-term investment |
| 0 | 0 | 0 | 944 |
Accounts receivables |
| 2,171 | 1,523 | 2,856 | 4,444 |
Inventories |
| 4,483 | 4,831 | 4,266 | 4,846 |
Deferred income taxes |
| 0 | 0 | 876 | 0 |
Other current assets |
| 3,120 | 4,042 | 4,459 | 4,538 |
Total current assets |
| 10,135 | 11,018 | 13,331 | 15,462 |
Gross property plant... |
| 11,845 | 12,536 | 13,434 | 15,033 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 11,845 | 12,536 | 13,434 | 15,033 |
Work in Progress |
| 1,418 | 854 | 1,215 | 1,190 |
Miscellaneous Investment |
| 2,121 | 2,452 | 793 | 1,447 |
Deferred income taxes |
| 0 | 0 | 191 | 937 |
Intangible assets |
| 2,565 | 2,914 | 601 | 561 |
Goodwill |
| 0 | 0 | 34,551 | 35,330 |
Other long-term assets |
| 6 | 32 | 1,819 | 1,806 |
Total non-current assets |
| 17,954 | 18,787 | 52,604 | 56,303 |
Total assets |
| 28,089 | 29,805 | 65,934 | 71,765 |
Short-term debt |
| 4,068 | 4,224 | 3,850 | 3,933 |
Accounts Payable... |
| 1,514 | 870 | 856 | 1,859 |
Provisions |
| 713 | 799 | 190 | 220 |
Taxes Payable |
| 0 | 0 | 469 | 606 |
Deferred Revenues |
| 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 |
Other current liabilities |
| 4,752 | 3,625 | 4,572 | 5,159 |
Total current liabilities |
| 11,048 | 9,517 | 9,937 | 11,777 |
Long-term debt |
| 3,302 | 4,189 | 4,601 | 5,250 |
Investments Liabilities |
| 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 629 | 774 | 994 | 1,321 |
Provisions |
| 733 | 805 | 2,214 | 2,343 |
Capital Leases |
| 0 | 0 | 0 | 0 |
Other longterm liabilities |
| 0 | 0 | 49 | 0 |
Total non-current liabilities |
| 4,664 | 5,768 | 7,858 | 8,914 |
Total liabilities |
| 15,712 | 15,285 | 17,795 | 20,692 |
Share Capital |
| 161 | 161 | 0 | 323 |
Share premium |
| 0 | 0 | 0 | 0 |
Retained earnings |
| 12,217 | 14,354 | 48,140 | 50,751 |
Accumulated other equity |
| 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 4 | 0 | 0 |
Total Equity |
| 12,378 | 14,520 | 48,140 | 51,073 |
Total Liabilities and Equity |
| 28,089 | 29,805 | 65,934 | 71,765 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade |